Abstract
We performed a prospective study to evaluate the types and characteristics of central nervous system (CNS) disorders in patients after hematopoietic stem cell transplantation. The study included 163 episodes of CNS disorders of which 58 (36%) were infections. Proven or probable infections were documented in 34 patients and included fungi (n = 10, 29%), viruses (n = 12, 35%), Toxoplasma spp. (n = 9, 27%) and bacteria (n = 3, 9%). Non-infectious neurological disorders (n = 105, 64%) frequently encompassed metabolic/drug-induced abnormalities (n = 28, 27%) or cerebral vascular events (n = 22, 21%). Median onset times were later for infectious (day + 101) vs non-infectious neurological disorders (day + 50, p = 0.009). An unremarkable cranial CT scan was found in 33% of infection episodes. Absence of cerebrospinal fluid pleocytosis despite a normal or increased peripheral blood white blood cell count occurred in 26% of infections. Day-30 mortality rates were significantly higher for fungal (87%) vs non-fungal infections (40%, p < 0.001). Significantly higher mortality rates were also documented for cerebral vascular events than for other non-infectious disorders (86% vs 34%, p < 0.001). Our prospective study shows that diagnostic findings in CNS infections might differ between hematopoietic stem cell transplant recipients and immunocompetent hosts. Special awareness and timely initiation of adequate diagnostics are crucial to improve the prognosis of these patients.
Similar content being viewed by others
References
Schmidt-Hieber M, Silling G, Schalk E et al (2016) CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 27(7):1207–1225. https://doi.org/10.1093/annonc/mdw155
Dulamea AO, Lupescu IG (2018) Neurological complications of hematopoietic cell transplantation in children and adults. Neural Regen Res 13(6):945–954. https://doi.org/10.4103/1673-5374.233431
Schwartz S, Ruhnke M, Ribaud P et al (2005) Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 106(8):2641–2645. https://doi.org/10.1182/blood-2005-02-0733
Schmidt-Hieber M, Schwender J, Heinz WJ et al (2011) Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents. Haematologica 96(1):142–149. https://doi.org/10.3324/haematol.2010.029876
Wu M, Huang F, Jiang X et al (2013) Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation. PLoS One 8(10):e77805. https://doi.org/10.1371/journal.pone.0077805
Bhatt VR, Balasetti V, Jasem JA et al (2015) Central nervous system complications and outcomes after allogeneic hematopoietic stem cell transplantation. Clin Lymphoma Myeloma Leuk 15(10):606–611. https://doi.org/10.1016/j.clml.2015.06.004
Dowling MR, Li S, Dey BR et al (2018) Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact. Bone Marrow Transplant 53(2):199–206. https://doi.org/10.1038/bmt.2017.239
Sostak P, Padovan CS, Yousry TA et al (2003) Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 60(5):842–848
Ogata M, Satou T, Kadota Ji et al (2013) Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis 57(5):671–681. https://doi.org/10.1093/cid/cit358
Ogata M, Fukuda T, Teshima T (2015) Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know. Bone Marrow Transplant 50(8):1030–1036. https://doi.org/10.1038/bmt.2015.76
Schwartz S, Kontoyiannis DP, Harrison T et al (2018) Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol 17(4):362–372. https://doi.org/10.1016/S1474-4422(18)30030-9
Abidi MZ, Hari P, Chen M et al (2019) Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is assohttps://doi.org/10.1038/s41409-019-0457-9ciated with poor patient outcomes: a CIBMTR contemporary longitudinal study. Bone Marrow Transplant. 54:1354–1360. https://doi.org/10.1038/s41409-019-0457-9
Antonini G, Ceschin V, Morino S et al (1998) Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology 50(5):1441–1445
Bleggi-Torres LF, de Medeiros BC, Werner B et al (2000) Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant 25(3):301–307. https://doi.org/10.1038/sj.bmt.1702140
Sostak P, Padovan CS, Eigenbrod S et al (2010) Cerebral angiitis in four patients with chronic GVHD. Bone Marrow Transplant 45(7):1181–1188. https://doi.org/10.1038/bmt.2009.323
Correa DD, Wang Y, West JD et al (2016) Prospective assessment of white matter integrity in adult stem cell transplant recipients. Brain Imaging Behav 10(2):486–496. https://doi.org/10.1007/s11682-015-9423-3
Sullivan KM (1999) Graft-versus-host-disease. In: Thomas E, Blume K, Forman SJ (eds) Hematopoietic Cell Transplantation, 2nd edn. Blackwell Science, Boston, MA, pp 515–526
de Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46(12):1813–1821. https://doi.org/10.1086/588660
Granerod J, Cunningham R, Zuckerman M et al (2010) Causality in acute encephalitis: defining aetiologies. Epidemiol Infect 138(6):783–800. https://doi.org/10.1017/S0950268810000725
Berger JR, Aksamit AJ, Clifford DB et al (2013) PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section. Neurology 80(15):1430–1438. https://doi.org/10.1212/WNL.0b013e31828c2fa1
Hagensee ME, Bauwens JE, Kjos B et al (1994) Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984–1992. Clin Infect Dis 19(3):402–408. https://doi.org/10.1093/clinids/19.3.402
Denier C, Bourhis JH, Lacroix C et al (2006) Spectrum and prognosis of neurologic complications after hematopoietic transplantation. Neurology 67(11):1990–1997. https://doi.org/10.1212/01.wnl.0000247038.43228.17
Safdieh JE, Mead PA, Sepkowitz KA et al (2008) Bacterial and fungal meningitis in patients with cancer. Neurology 70(12):943–947. https://doi.org/10.1212/01.wnl.0000305960.85546.5f
Candoni A, Klimko N, Busca A et al (2018) Fungal infections of the central nervous system and paranasal sinuses in onco-hematologic patients. Epidemiological study reporting the diagnostic-therapeutic approach and outcome in 89 cases. Mycoses. https://doi.org/10.1111/myc.12884
Mulanovich VE, Ahmed SI, Öztürk T et al (2011) Toxoplasmosis in allo-SCT patients: risk factors and outcomes at a transplantation center with a low incidence. Bone Marrow Transplant 46(2):273–277. https://doi.org/10.1038/bmt.2010.102
Martino R, Bretagne S, Einsele H et al (2005) Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 40(1):67–78. https://doi.org/10.1086/426447
Fricker-Hidalgo H, Bulabois CE, Brenier-Pinchart MP et al (2009) Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clin Infect Dis 48(2):e9–e15. https://doi.org/10.1086/595709
Schwartz S, Ruhnke M, Ribaud P et al (2007) Poor efficacy of amphotericin B-based therapy in CNS aspergillosis. Mycoses 50(3):196–200. https://doi.org/10.1111/j.1439-0507.2007.01345.x
Falci DR, Pasqualotto AC (2013) Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections. Infect Drug Resist 6:163–174. https://doi.org/10.2147/IDR.S51340
Peixoto D, Gagne LS, Hammond SP et al (2014) Isavuconazole treatment of a patient with disseminated mucormycosis. J Clin Microbiol 52(3):1016–1019. https://doi.org/10.1128/JCM.03176-13
Wiederhold NP, Kovanda L, Najvar LK et al (2016) Isavuconazole is effective for the treatment of experimental cryptococcal meningitis. Antimicrob Agents Chemother 60(9):5600–5603. https://doi.org/10.1128/AAC.00229-16
Pruitt AA (2010) Central nervous system infections in cancer patients. Semin Neurol 30(3):296–310. https://doi.org/10.1055/s-0030-1255216
Author information
Authors and Affiliations
Contributions
AU and DE designed the research. MSH, DE, AU, PL, JM, RM, MR, PJS, CR, MF, JB, KSE, HE, EF, LR, RS, ABR, CI, MC, GT, JW, NK, MM, SC and JS provided important clinical data and/or performed statistical analyses. MSH wrote the first draft of the manuscript. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
MSH received travel support from the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). The other authors declared no conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Schmidt-Hieber, M., Engelhard, D., Ullmann, A. et al. Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT. J Neurol 267, 430–439 (2020). https://doi.org/10.1007/s00415-019-09578-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-019-09578-5